Overview

Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro... More >>

Recent NewsMore >>
DateTitle 
06/27/16LabCorp Announces Launch of New Companion Diagnostic for Non-Small Cell Lung Cancer
The Roche cobas® EGFR Mutation Test v2 is the First Blood-Based Liquid Biopsy Test Approved by FDA for Clinical Use BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 27, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the availability of a new application for the companion diagnostic associated with the use of Tarceva® for the treatment of certain patients with non-small cell lung cancer (NSCLC). The Roche... 
Printer Friendly Version
06/08/16LabCorp is Scheduled to Present at the 36th Annual William Blair Growth Stock Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 8, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the 36th Annual William Blair Growth Stock Conference. LabCorp’s presentation is planned for Tuesday, June 14, 2016 at 3:50 PM (ET). A live audio webcast of the presentation will be available via the Company website at www.labcorp.com and archived for replay. About LabCorp... 
Printer Friendly Version
06/06/16LabCorp Announces the Availability of the RealStar® Zika Virus Test
altona Diagnostics’ RealStar® Zika Virus RT-PCR Kit U.S. Has Received FDA Emergency Use Authorization BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 6, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the RealStar® Zika Virus RT-PCR Kit U.S. from altona Diagnostics GmbH. The test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug... 
Printer Friendly Version
06/01/16One Year After Launch, BRCA Share™ Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk
Co-Founded by Quest Diagnostics and Inserm, with LabCorp as First Member, BRCA Share is now the Largest Open BRCA Datashare of Curated BRCA Variants Clinically Suitable for Patient Management MADISON, N.J., PARIS, France, BURLINGTON, N.C. – June 1, 2016 – BRCA Share, a public-private BRCA gene datashare initiative, today announced the public release of a large collection of new data on genetic variants in the BRCA1 and BRCA2 genes. Mutations of these genes raise the risk of breast, ovarian and... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
LH (Common)
ExchangeNYSE
Price$125.53
Change Stock is Down 4.09
Intraday High$130.23
Intraday Low$124.53
Volume1,900,697
Data as of 06/27/16
4:02 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2014 Annual Report

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release